The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 35,417 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| ADAPTIVE BIOTECHNOLOGIES | Common | 00650F109 | 9,660 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | 41,615 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 5,554 | 6,240,000 | SH | SOLE | 6,240,000 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | Common | 019770106 | 30,303 | 1,128,594 | SH | SOLE | 1,128,594 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 145,425 | 7,500,000 | SH | SOLE | 7,500,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 124,800 | 10,000,000 | SH | SOLE | 10,000,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 118,927 | 840,000 | SH | SOLE | 840,000 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | Common | 04269X105 | 92,660 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 226,846 | 1,970,000 | SH | SOLE | 1,970,000 | 0 | 0 | ||
| ATHENEX INC | Common | 04685N103 | 91,179 | 4,605,000 | SH | SOLE | 4,605,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | Common | 09060J106 | 34,526 | 7,424,867 | SH | SOLE | 7,424,867 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 181,150 | 2,115,000 | SH | SOLE | 2,115,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 19,332 | 2,700,000 | SH | SOLE | 2,700,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 4,424 | 1,105,999 | SH | SOLE | 1,105,999 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 49,970 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | Common | G46188101 | 96,240 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 291,270 | 21,000,000 | SH | SOLE | 21,000,000 | 0 | 0 | ||
| INTEC PHARMA LTD | Common | M53644106 | 3,559 | 820,000 | SH | SOLE | 820,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 263,653 | 10,752,585 | SH | SOLE | 10,752,585 | 0 | 0 | ||
| iShares Russell 2000 | ETF | 464287655 | 110 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| KODIAK SCIENCES INC | Common | 50015M109 | 6,751 | 577,021 | SH | SOLE | 577,021 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 37,732 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MEDICINES CO | Common | 584688105 | 33,735 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 397,838 | 3,862,500 | SH | SOLE | 3,862,500 | 0 | 0 | ||
| MYOKARDIA INC | Common | 62857M105 | 68,943 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
| PACIRA BIOSCIENCES INC | Common | 695127100 | 17,396 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | Common | 69366J200 | 30,780 | 684,000 | SH | SOLE | 684,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | Common | 77313F106 | 4,286 | 285,714 | SH | SOLE | 285,714 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 212,730 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 5,463 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
| TELIGENT INC | Common | 87960W104 | 3,296 | 5,231,206 | SH | SOLE | 5,231,206 | 0 | 0 | ||
| TRICIDA INC | Common | 89610F101 | 86,812 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 23,664 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 96,755 | 2,025,000 | SH | SOLE | 2,025,000 | 0 | 0 | ||